Unicycive Therapeutics, Inc. (UNCY)
NCM – Real vaqt narxi. Valyuta: USD
8.17
+0.22 (2.77%)
Yopilishda: May 12, 2026, 4:00 PM EDT
8.01
-0.16 (-1.96%)
Bozordan keyin: May 12, 2026, 7:12 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
8.17
+0.22 (2.77%)
Yopilishda: May 12, 2026, 4:00 PM EDT
8.01
-0.16 (-1.96%)
Bozordan keyin: May 12, 2026, 7:12 PM EDT
Unicycive Therapeutics, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlarda buyrak kasalliklarini davolash uchun terapiyalarni aniqlaydi, ishlab chiqadi va tijoratlashtiradi. U dializdagi surunkali buyrak kasalligi bo'lgan bemorlarda giperfosfatemiya davolash uchun mo'ljallangan lantan asosidagi fosfat bog'lovchi vosita bo'lgan oksilantan karbonatni ishlab chiqadi; va o'tkir buyrak shikastlanishini davolash uchun I fazali klinik sinovda va surunkali buyrak kasalligini davolash uchun preklinik bosqichda bo'lgan nikotinamid ester hosilasi va selektiv ATPga sezgir mitoxondriyal kaliy kanal aktivatori UNI-494ni ishlab chiqadi. Kompaniya 2016 yilda tashkil etilgan va shtab-kvartirasi Mountain View, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Pramod Gupta Ph.D. | Executive Vice President of Pharmaceutical and Business Operations |
| Dr. Shalabh K. Gupta M.D., MPA | Founder, Chairman, CEO & President |
| Mr. Douglas Jermasek M.B.A. | Executive Vice President of Corporate Strategy |
| Mr. John W. Townsend C.P.A. | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | S-8 | ea0288752-s8_unicycive.htm |
| 2026-04-06 | 8-K | ea0285174-8k_unicycive.htm |
| 2026-03-30 | 8-K | ea0283942-8k_unicycive.htm |
| 2025-11-14 | 8-K | ea0265675-8k_unicycive.htm |
| 2025-11-12 | 8-K | ea0265227-8k_unicycive.htm |
| 2025-10-28 | 8-K | ea0262723-8k_unicycive.htm |
| 2025-08-18 | 8-K | ea0253753-8k_unicycive.htm |
| 2025-08-15 | 8-K | ea0253521-8k_unicycive.htm |
| 2025-08-14 | 8-K | ea0253163-8k_unicy.htm |
| 2025-08-14 | 10-Q | ea0252599-10q_unicycive.htm |